573 related articles for article (PubMed ID: 18028024)
1. Prostatic transitional cell carcinoma: pathologic features and clinical management.
Shen SS; Lerner SP
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
[TBL] [Abstract][Full Text] [Related]
2. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.
Lerner SP; Shen S
Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459
[TBL] [Abstract][Full Text] [Related]
3. [Transitional cell carcinoma involvement of the prostate].
Bassi P; De Lisa A; Usai P; Pinto F; Sacco E
Ann Urol (Paris); 2005 Nov; 39 Suppl 5():S113-9. PubMed ID: 16425728
[TBL] [Abstract][Full Text] [Related]
4. [Prostatic urothelial location of a tumor of the bladder].
Coulange C; Lechevallier E; de Fromont M
Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
[TBL] [Abstract][Full Text] [Related]
5. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
6. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F; Chebil G; Månsson W
Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
[TBL] [Abstract][Full Text] [Related]
7. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
8. The conundrum of prostatic urethral involvement.
Ingimarsson JP; Seigne JD
Urol Clin North Am; 2013 May; 40(2):249-59. PubMed ID: 23540782
[TBL] [Abstract][Full Text] [Related]
9. Urothelial carcinoma of the prostate.
Goebbels R; Amberger L; Wernert N; Dhom G
Appl Pathol; 1985; 3(4):242-54. PubMed ID: 3842265
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
11. [Membranous and penile urethral involvement in bladder cancer patients-- review of cystoprostatourethrectomy specimens].
Shimizu T; Suzuki T; Yamanaka H; Satoh J; Suzuki K
Hinyokika Kiyo; 1994 Oct; 40(10):869-72. PubMed ID: 7992699
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
Mungan MU; Canda AE; Tuzel E; Yorukoglu K; Kirkali Z
Eur Urol; 2005 Nov; 48(5):760-3. PubMed ID: 16005563
[TBL] [Abstract][Full Text] [Related]
13. Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma.
Lerner SP; Colen J; Shen S
Curr Opin Urol; 2008 Sep; 18(5):508-12. PubMed ID: 18670276
[TBL] [Abstract][Full Text] [Related]
14. [Superficial carcinoma of the bladder. The pT1 G3 tumor: progression, recurrence, and survival. Treatment].
Nogueira March JL; Ojea Calvo A; Castro Iglesias AM; Rodríguez Iglesias B
Actas Urol Esp; 1992 Oct; 16(9):682-90. PubMed ID: 1488920
[TBL] [Abstract][Full Text] [Related]
15. [New concepts in the management of MIBC in 2010].
Pignot G; Molinié V; Coloby P; Culine S; Gravis G; Rossi D; Theodore C; Zerbib M
Prog Urol; 2011 Mar; 21 Suppl 2():S38-42. PubMed ID: 21397826
[TBL] [Abstract][Full Text] [Related]
16. [Urothelial bladder carcinoma in situ involving the whole urinary tract. One case (author's transl)].
Bellocq JP; Lassabe-Roth C; Viville C; Camey M; Batzenschlager A
J Urol (Paris); 1982; 88(4):255-60. PubMed ID: 7202029
[TBL] [Abstract][Full Text] [Related]
17. "Denuding cystitis" and in situ urothelial carcinoma.
Elliott GB; Moloney PJ; Anderson GH
Arch Pathol; 1973 Aug; 96(2):91-4. PubMed ID: 4718234
[No Abstract] [Full Text] [Related]
18. Predictive factors for prostatic involvement by transitional cell carcinoma of the bladder.
Tabibi A; Simforoosh N; Parvin M; Abdi H; Javaherforooshzadeh A; Farrokhi F; Soltani MH
Urol J; 2011; 8(1):43-7. PubMed ID: 21404202
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma in situ: comments on the pathobiology of a paradox.
Weinstein RS; Miller AW; Pauli BU
Urol Clin North Am; 1980 Oct; 7(3):523-31. PubMed ID: 7456164
[TBL] [Abstract][Full Text] [Related]
20. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens.
Lapham RL; Grignon D; Ro JY
Semin Diagn Pathol; 1997 May; 14(2):109-22. PubMed ID: 9179972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
